Media & Events

Keep up-to-date on the latest media coverage and events for IceCure Medical.

Filter by:

News

ICECURE PLATINUM SPONSOR OF THE 20TH WORLD CONGRESS OF THE INTERNATIONAL SOCIETY OF CRYOSURGERY, SEPT 4-5, 2019.

Demonstrating our commitment to advance the treatment of cancer using cryosurgery, we are proud to be the Platinum sponsor of the 20th World Congress of the International Society of Cryosurgery: Sept 4-5, 2019, Haifa, Israel. With talks from top experts

Read More >

News

IceCure Medical Announces New Category III CPT Code for Breast Cryoablation Therapy, Issued by the American Medical Association

New Category III CPT Code expected to support further adoption of minimally invasive cryoablation treatments for breast cancer. Learn more.

Read More >

IceCure Medical Announces New Category III CPT Code for Breast Cryoablation Therapy, Issued by the American Medical Association

News

IceCure featured in the leading interventional oncology news outlet, Interventional News

IceCure’s landmark US clinical trial, ICE3, for nitrogen-based cryoablation of small, low-risk, early stage malignant breast tumors without subsequently removing them, featured in Interventional News. Cryoablation shows promise in treating low-risk breast cancers. “If the positive preliminary findings are maintained

Read More >

Kenneth-R-Tomkovich- lead PI of ICE3 cryoablation breast cancer study

Events

IceCure to attend SIO, 8 June – 11 June 2019

Visit us at The Society of Interventional Oncology’s next scientific meeting, SIO 2019 (WCIO) booth #32, 8-11 June, Boston, USA to learn more about our next generation liquid-nitrogen-based cryoablation system, ProSense. Join us on Monday June 10th for our hands-on

Read More >

WCIO2019 - The Society of Interventional Oncology next scientific meeting

Events

IceCure to attend ASBrS 20th Annual Meeting, 30 April – 5 May 2019

Visit us at the American Society of Breast Surgeons (ASBrS) 20th Annual Meeting. Join us at booth #314 to learn more about our next generation liquid-nitrogen-based cryoablation system, ProSense, and to hear more from our landmark ICE3 breast cancer trial

Read More >